How do today’s diagnostic laboratories grow, stay compliant, and remain profitable while facing staffing shortages, payer complexity, and soaring demand for advanced testing?
In this special Office Hours episode, we sit down with Ashish Dua, President and Co-Founder of Glidian, a company recently welcomed into the Infinx family. With deep expertise in laboratory workflows and prior authorization automation, Ashish shares how Glidian is helping labs—from scrappy startups to academic medical centers—scale faster, reduce overhead, and win physician loyalty by solving access barriers.
The conversation explores how AI is transforming lab revenue cycle operations, not just by removing administrative burden, but by enabling entirely new workflows—such as acting as prior auth agents for physicians and training algorithms to interpret analog responses from payers. We’ll also discuss how shifting the burden of prior authorization from providers to labs is creating a new dynamic where labs can move from being cost centers to true revenue drivers.
Ashish brings perspective from working with labs that perform high-volume molecular diagnostics, including non-invasive prenatal testing (NIPT) and hereditary cancer screenings like BRCA1/2, offering a timely view into what it really takes to operate a modern, financially sustainable lab in 2025.
Request a demo of our revenue solutions to learn more.